| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Castelein Caley | Director | C/O TOURMALINE BIO, INC., 27 WEST 24TH STREET, SUITE 702, NEW YORK | /s/ Brad Middlekauff, Attorney-in-Fact | 2025-10-17 | 0001355758 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TRML | Common Stock | Gift | $0 | -522 | -0.1% | $0.00 | 516K | Oct 15, 2025 | Direct | |
| holding | TRML | Common Stock | 432K | Oct 15, 2025 | By KVP Capital, LP | F1, F2 |
| Id | Content |
|---|---|
| F1 | Gives effect to in-kind distribution of shares by KVP Capital, LP ("KVP") to its limited partner for no consideration, subsequent to the Reporting Person's most recent filing, which represented a change in the form of the Reporting Person's ownership that was not required to be reported under Section 16. |
| F2 | These shares are held by KVP. The Reporting Person is the Managing Member of KVP Capital GP, LLC, the General Partner of KVP and, as such, has sole voting and investment power with respect to the shares held by KVP. The Reporting Person disclaims beneficial ownership of the shares held by KVP except to the extent of his pecuniary interest therein and this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |